AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 81 min read$IRMD

ALLEN MONTY K sold $123K of IRMD

ALLEN MONTY K sold 1,419 shares of IRADIMED CORP (IRMD) at an average of $86.41 ($86.35–$86.44, $0.12M total) across 2 trades on 2026-09-03.

Original reporting
SEC EDGAR · ALLEN MONTY K
Published Sep 8, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 9:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$IRMD
Bearish
medium confidence
Mentioned
$IRMD
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IRMDBearishLow
01

Why it matters

A modest insider sell may prompt short‑term traders to watch IRMD for slight price weakness.

02

Market read

Primary relevance to IRMD shareholders; limited broader market impact.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed in the filing.

Relevance 4/10Novelty 4/10Timing: filed 2026-09-08

Background

Form 4 filings disclose insider transactions; this one reports a director's sale of IRADIMED shares.

Company-level read

Ticker impact

$IRMDBearishMedium confidence
Context

Director Monty K. Allen sold 1,419 shares of IRADIMED Corp for $122,622, reducing his stake to 19,581 shares.

Expected impact

Potential short-term dip of 1‑2% as the market digests the sale.

Evidence & confidence

Director sales are often viewed as a bearish signal, but the amount is small relative to float.

Market effects

Sector

Minimal impact on the broader biotech sector; insider activity is company‑specific.

Regional

No significant regional effect; confined to IRADIMED investors.

Global

Low global relevance; limited to shareholders and short‑term traders.

Counterpoint

What could challenge this read

The sale could be unrelated to company fundamentals and merely portfolio rebalancing.

Key entities

  • Company
    IRADIMED Corp

    Biotech firm listed on NASDAQ under ticker IRMD.

  • Insider
    Monty K. Allen

    Director of IRADIMED Corp.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

IRMD insider trading history →

Related articles

AUG 8
$IRMDMedAI 9/10

IRadimed (IRMD) Q2 2026 Earnings Call Transcript

IRadimed (IRMD) reported Q2 2026 revenue of $20.5 million, up 0.5% from $20.4 million a year earlier. GAAP diluted EPS was $0.41 versus $0.45, and non-GAAP EPS was $0.46. Gross margin fell to 74% from 78% due to higher manufacturing costs during the 3870 pump ramp. Q3 revenue guidance is $23.0 to $24.5 million; full-year 2026 revenue guidance is $91 to $96 million.

fool.com7 min
MAY 29
$IRMDMedAI 9/10

Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report

Iradimed Corp (IRMD) reported Q1 2026 results on May 1. The company said revenue rose 13% year over year to $22 million and net income increased 24% to $5.8 million, or $0.45 per share. Iradimed also launched its next-generation 3870 MRI-compatible IV infusion pump in Q1, with shipments expected to begin in Q2. For Q2, it forecast revenue of $20–$21 million and GAAP EPS of $0.40–$0.44; full-year 2026 revenue of $91–$96 million and GAAP EPS of $1.90–$2.05.

finance.yahoo.com4 min
OCT 22
$DOLELow

Pale Fire Capital SE (Senkypl Dusan, Barta Jan) purchased $8.6M of DOLE (indirect holdings)

Pale Fire Capital SE purchased 648,356 indirectly-held shares of Dole plc (DOLE) at an average of $13.19 ($13.12–$13.39, $8.55M total) across 3 trades over 2026-10-20 to 2026-10-22. Filed jointly with Pale Fire Capital SICAV a.s. (10% owner), Pale Fire Capital investicni spolecnost a.s. (10% owner), Senkypl Dusan (10% owner) and Barta Jan (10% owner).

SEC EDGAR1 min